Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Adds a consolidated Locations section listing Arkansas, California, Jilin, Hauts De Seine, FI, and Barcelona, and updates the page revision to v3.3.3. Removes the separate Arkansas Locations, California Locations, Jilin Locations, Hauts De Seine Locations, FI Locations, and Barcelona Locations entries.
    Difference
    0.7%
    Check dated 2025-12-23T17:29:11.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T20:55:45.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added EU registry identifier 2024-512050-13-00 to the study record and updated dates; removed the older EudraCT number and a government-funding notice.
    Difference
    0.6%
    Check dated 2025-11-17T18:12:46.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page; the study details, eligibility criteria, and locations remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:39.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The Locations section now lists 11 sites, adding L'Hospitalet de Llobregat, Barcelona, Spain, and removing Lyon, France. The total number of locations changed from 12 to 11, and the L'Hospitalet de Llobregat entry was reformatted from Catalonia to Barcelona.
    Difference
    0.5%
    Check dated 2025-10-27T09:23:52.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:42:19.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.